“Tumour Microenvironment Modulation to Overcome Checkpoint Resistance: Where the Preclinical Rationale Holds”. 2026. Translational Medicine & Therapeutics Journal 5 (2): 28-36. https://doi.org/10.5281/zenodo.22649559.